Collection

SAGE meetings, July 2021

Minutes and papers from the Scientific Advisory Group for Emergencies (SAGE) meetings held in July 2021.

• From: Scientific Advisory Group for Emergencies
• Published: 12 July 2021
• Last updated: 11 February 2022
  Show all updates

  1. 11 February 2022

     Added 1 paper to SAGE 94 meeting.

  2. 4 February 2022

     Added 1 page to SAGE 94.

  3. 20 August 2021

     2 ONS reports added (SAGE meeting 94).

  4. 13 August 2021

     Addition of 1 paper to SAGE 93 and 4 papers to SAGE 94.

  5. 6 August 2021

     Addition of 1 set of minutes and 2 papers to SAGE 94.

  6. 30 July 2021

     Addition of 9 papers to SAGE 94.

  7. 23 July 2021

     Addition of 1 paper to SAGE 93.

  8. 16 July 2021

     Addition of 3 papers under SAGE 93.

  9. 12 July 2021

     First published.

Meeting 93, 7 July 2021

• SAGE 93 minutes: Coronavirus (COVID-19) response, 7 July 2021
  • 12 July 2021
  • Transparency data
• SPI-M-O: Summary of further modelling of easing restrictions – Roadmap Step 4 on 19 July 2021, 7 July 2021
  • 13 May 2022
  • Research and analysis
• University of Warwick: Roadmap scenarios and sensitivity – Step 4, 6 July 2021
  • 12 July 2021
  • Research and analysis
• Imperial College London: Evaluating the roadmap out of lockdown for England: modelling the delayed Step 4 of the roadmap in the context of the Delta variant, 7 July 2021
  • 12 July 2021
  • Research and analysis
• LSHTM: Updated roadmap assessment – prior to delayed Step 4, 7 July 2021
  • 12 July 2021
  • Research and analysis
• JUNIPER: Transitioning from non-pharmaceutical interventions to vaccination to control COVID-19 transmission, 7 July 2021
  • 12 July 2021
  • Research and analysis
• Dynamic CO-CIN report to SAGE and NERVTAG, 6 July 2021
  • 12 July 2021
  • Research and analysis
• PHE: Investigation of SARS-CoV-2 variants of concern – variant risk assessments for SARS-CoV-2 variant, Delta, 8 July 2021
  • 16 July 2021
  • Research and analysis
• PHE: Investigation of SARS-CoV-2 variants of concern – variant risk assessments for SARS-CoV-2 variant, Lambda, 8 July 2021
  • 16 July 2021
  • Research and analysis
• PHE: Review of longitudinal studies on immunity from SARS-CoV-2, 7 July 2021
  • 16 July 2021
  • Research and analysis
• SPI-M-O: Consensus statement on COVID-19, 7 July 2021
  • 16 July 2021
  • Research and analysis
• SPI-M-O: Medium-term projections, 7 July 2021
  • 16 July 2021
  • Research and analysis
• PHE: Investigation of SARS-CoV-2 variants of concern – routine variant data update, England, version 8, 7 July 2021
  • 23 July 2021
  • Research and analysis
• HDR UK: COVID-19 health data research – weekly update, 6 July 2021
  • 6 August 2021
  • Research and analysis
• CMMID: Social contacts in the UK from the CoMix social contact survey
  • 14 January 2022
  • Research and analysis
• UKHSA: SARS-COV-2 variants in risk assessment grid
  • 18 December 2021
  • Research and analysis

Meeting 94, 22 July 2021

• SAGE 94 minutes: Coronavirus (COVID-19) response, 22 July 2021
  • 4 February 2022
  • Transparency data
• ONS: Short report on Long COVID, 22 July 2021
  • 30 July 2021
  • Research and analysis
• Dynamic CO-CIN report to SAGE and NERVTAG, 21 July 2021
  • 30 July 2021
  • Research and analysis
• International vaccination: Potential impact on viral evolution and UK public health, 21 July 2021
  • 26 October 2021
  • Research and analysis
• SPI-M-O: Medium-term projections, 21 July 2021
  • 30 July 2021
  • Research and analysis
• SPI-M-O: Statement on their concerns for next few months, 14 July 2021
  • 26 October 2021
  • Research and analysis
• How long will vaccines continue to protect against COVID-19?, 30 July 2021
  • 30 July 2021
  • Research and analysis
• Long term evolution of SARS-CoV-2, 26 July 2021
  • 30 July 2021
  • Research and analysis
• RAEng: Infection Resilient Environments – Buildings that keep us healthy and safe, 19 July 2021
  • 19 July 2021
  • Research and analysis
• AMS: COVID-19 preparing for the future – Looking ahead to winter 2021, 2022 and beyond, 15 July 2021
  • 15 July 2021
  • Research and analysis
• PHE: SARS-COV-2 variants in risk assessment – variants detected in the UK, 21 July 2021
  • 6 August 2021
  • Research and analysis
• VEEP: Vaccine effectiveness table, 16 July 2021
  • 6 August 2021
  • Research and analysis
• PHE: Investigation of SARS-CoV-2 variants of concern – variant risk assessments for SARS-CoV-2 variant, Delta, 23 July 2021
  • 13 August 2021
  • Research and analysis
• PHE: Investigation of SARS-CoV-2 variants of concern – variant risk assessments for SARS-CoV-2 variant, Beta, 23 July 2021
  • 13 August 2021
  • Research and analysis
• PHE: Investigation of novel SARS-CoV-2 variants of concern (England) – Technical briefing 19, 23 July 2021
  • 13 August 2021
  • Research and analysis
• PHE: Investigation of SARS-CoV-2 variants of concern – routine variant data update, England, version 9, 23 July 2021
  • 13 August 2021
  • Research and analysis
• ONS: Impact of Delta and calendar time on symptoms reported by individuals testing swab positive – preliminary analysis of data (to 12 July 2021), 22 July 2021
  • 20 August 2021
  • Research and analysis
• ONS: Impact of Delta and calendar time on vaccine effectiveness against new SARS-CoV-2 infection and Ct/viral burden in infections post-vaccination – preliminary analysis on data (to 12 July 2021), 22 July 2021
  • 20 August 2021
  • Research and analysis
• ONS: Anti-spike Immunoglobulin G (IgG) antibody response after second vaccine dose - preliminary analysis on data to 5 July 2021, 22 July 2021
  • 16 September 2021
  • Research and analysis
• NERVTAG: Extraordinary NERVTAG COVID-19 meeting on Human Challenge Studies, 9 July 2021
  • 4 February 2022
  • Research and analysis
• Academics: Modeling the factors that influence exposure to SARS-CoV-2 on a subway train carriage, 22 July 2021
  • 11 February 2022
  • Research and analysis